245 Results were found on Technologies
Sub Category Name
A Novel Nanoparticle that Selectively Delivers RNAi Oligonucelotides to Tumors, Preventing Side Effects to Tissues
UNMET NEEDPancreatic cancer numbers among the most aggressive cancers known today. The overwhelming majority of pancreatic cancer patients pass away within just a year of diagnosis. However, a small minority of patients may live several years with the disease. Our findings pinpoint the inverse correlation between a known oncogene (PLK1) and the expression of an […] Read More >
Dynamic structured light projector based on resonance domain diffractive optical elements
The field is the 3D scanning for sensing, imaging, 3D printing and computer-integrated manufacturing. We develop a critical device for dynamic creation of the structured light (SL) patterns that was a bottleneck in triangulation-based 3D sensing with active illumination. Resorting to matured technology of lasers arrays as well as to emerging academically proven technology of […] Read More >
Block polyester copolymers by ring opening polymerization employing new catalysts
Poly(lactic acid) (PLA) is a plastic material derived from annually-renewable resources, which decomposes post-consumption to non-toxic materials. PLA is produced by the catalyzed ring opening polymerization (ROP) of lactide. PLA is attracting considerable current interest and has found various commodity (packaging, fibres, etc.) and biomedical (sutures, stents, tissue engineering, drug release) applications. Substantial worldwide effort […] Read More >
Water-Tech Laboratory
Our group focuses on developing water-treatment processes and technologies by introducing natural and induced photons, radicals, reactive species and nanoparticles into the water, using UV photocatalysis- and ozone-based advanced oxidation processes (AOPs), as well as Reuse technologies via hybrid biofiltration, ozonation and short soil aquifer treatment (SAT) of secondary effluent. We’ve assembled an AOP pilot […] Read More >
An Oncolytic Virus That Exploits Immune Defects of Cancer Cells
An oncolytic virus for tumors of different etiology presenting defects in interferon signaling, designed as a potent, specific and safe therapy. Promising in-vivo murine melanoma model shows potential for development as a mono or an add-on to chemotherapy or check-point inhibitors. UNMET NEED On Nov. 2015 the FDA approved the first oncolytic virus based treatment. […] Read More >
Passive communications with time-varying metamaterials
The coming years will see a revolution by connecting everything to anyone, and RFID and similar technologies, will lead this 300B$ USD industry and 50B connected devices. Examining existing RFID standards suggests that the leading standard, called EPC Gen 2, is a standard in the 900MHz frequency which allows hundreds of tags to be read […] Read More >
HYDEN (HighlY DEgeNerate primers) – A Software for designing pairs of degenerate primers for a given set of DNA sequences
Overview HYDEN (HighlY DEgeNerate primers) is a program for designing pairs of degenerate primers for a given set of DNA sequences. HYDEN works well for large input sets of genomic sequences (e.g., hundreds of sequences of length 1Kbp). HYDEN is a batch (i.e., command-line, as opposed to graphical interface) program, available for Windows XP (downloadable […] Read More >
Synthetic 9-cis beta Carotene for treatment of retinal degeneration
9-cis β-carotene-rich is an effective treatment for retinal diseases. Its production in algae was a bottleneck of clinical trials. Now there is a new a synthetic method for its production. BACKGROUNDAge related macular degeneration (AMD) and Retinitis pigmentosa (RP) are a leading cause of vision incapacitation and blindness worldwide (>30 million people). In recent clinical […] Read More >
A Software Only Anti-Spoofing Defense System for In-Car CAN Bus Networks
Modern cars have multiple dedicated computers under the hood called “electronic control units” (ECUs). These ECUs control many aspects of the car’s operation and are connected to each other in a network that typically uses the CAN bus protocol, which bus is a serial protocol with no security components. Replacing CAN bus with another technology […] Read More >
Novel Specific Disease-Modifying PERK Activator for Huntington’s Disease
The need: There is no efficient therapy at present for Huntington’s disease (HD) nor for any other neurodegenerative disease, including Alzheimer’s and Parkinson’s diseases. No disease-modifying approaches exist. • Gene therapy-based clinical trials have failed so far, highlighting the need for other approaches. These include the recent interruption of antisense oligonucleotide clinical trials for HD. Background […] Read More >
